Receptor conformations involved in dopamine D 2L receptor functional selectivity induced by selected transmembrane-5 serine mutations

J. Corey Fowler, Supriyo Bhattacharya, Jonathan D. Urban, Nagarajan Vaidehi, Richard B. Mailman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Although functional selectivity is now widely accepted, the molecular basis is poorly understood. We have studied how aspects of transmembrane region 5 (TM5) of the dopamine D 2Lreceptor interacts with three rationally selected rigid ligands (dihydrexidine, dinapsoline, and dinoxyline) and the reference compounds dopamine and quinpirole. As was expected from homology modeling, mutation of three TM5 serine residues to alanine (S5.42A, S5.43A, S5.46A) had little effect on antagonist affinity. All three mutations decreased the affinity of the agonist ligands to different degrees, S5.46A being somewhat less affected. Four functions [adenylate cyclase (AC), extracellular signal-regulated kinase 1/2 phosphorylation (MAPK), arachidonic acid release (AA), and guanosine 5′-O-(3-thio)triphosphate binding (GTPγS)] were assessed. The intrinsic activity (IA) of quinpirole was unaffected by any of the mutations, whereas S5.42A and S5.46A mutations abolished the activity of dopamine and the three rigid ligands, although dihydrexidine retained IA at MAPK function only with S5.42A. Remarkably, S5.43A did not markedly affect IA for AC and MAPK for any of the ligands and eliminated AA activity for dinapsoline and dihydrexidine but not dinoxyline. These data suggest that this mutation did not disrupt the overall conformation or signaling ability of the mutant receptors but differentially affected ligand activation. Computational studies indicate that these D 2 agonists stabilize multiple receptor conformations. This has led to models showing the stabilized conformations and interhelical and receptor-ligand contacts corresponding to the different activation pathways stabilized by various agonists. These data provide a basis for understanding D 2L functional selectivity and rationally discovering functionally selective D 2 drugs.

Original languageEnglish (US)
Pages (from-to)820-831
Number of pages12
JournalMolecular pharmacology
Volume81
Issue number6
DOIs
StatePublished - Jun 1 2012

Fingerprint

Serine
Dopamine
Ligands
Mutation
Quinpirole
Adenylyl Cyclases
Arachidonic Acid
Guanosine 5'-O-(3-Thiotriphosphate)
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Alanine
Phosphorylation
Pharmaceutical Preparations
dihydrexidine
dinapsoline

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Fowler, J. Corey ; Bhattacharya, Supriyo ; Urban, Jonathan D. ; Vaidehi, Nagarajan ; Mailman, Richard B. / Receptor conformations involved in dopamine D 2L receptor functional selectivity induced by selected transmembrane-5 serine mutations. In: Molecular pharmacology. 2012 ; Vol. 81, No. 6. pp. 820-831.
@article{80200b1dc10742bc8fb7983024f4aedb,
title = "Receptor conformations involved in dopamine D 2L receptor functional selectivity induced by selected transmembrane-5 serine mutations",
abstract = "Although functional selectivity is now widely accepted, the molecular basis is poorly understood. We have studied how aspects of transmembrane region 5 (TM5) of the dopamine D 2Lreceptor interacts with three rationally selected rigid ligands (dihydrexidine, dinapsoline, and dinoxyline) and the reference compounds dopamine and quinpirole. As was expected from homology modeling, mutation of three TM5 serine residues to alanine (S5.42A, S5.43A, S5.46A) had little effect on antagonist affinity. All three mutations decreased the affinity of the agonist ligands to different degrees, S5.46A being somewhat less affected. Four functions [adenylate cyclase (AC), extracellular signal-regulated kinase 1/2 phosphorylation (MAPK), arachidonic acid release (AA), and guanosine 5′-O-(3-thio)triphosphate binding (GTPγS)] were assessed. The intrinsic activity (IA) of quinpirole was unaffected by any of the mutations, whereas S5.42A and S5.46A mutations abolished the activity of dopamine and the three rigid ligands, although dihydrexidine retained IA at MAPK function only with S5.42A. Remarkably, S5.43A did not markedly affect IA for AC and MAPK for any of the ligands and eliminated AA activity for dinapsoline and dihydrexidine but not dinoxyline. These data suggest that this mutation did not disrupt the overall conformation or signaling ability of the mutant receptors but differentially affected ligand activation. Computational studies indicate that these D 2 agonists stabilize multiple receptor conformations. This has led to models showing the stabilized conformations and interhelical and receptor-ligand contacts corresponding to the different activation pathways stabilized by various agonists. These data provide a basis for understanding D 2L functional selectivity and rationally discovering functionally selective D 2 drugs.",
author = "Fowler, {J. Corey} and Supriyo Bhattacharya and Urban, {Jonathan D.} and Nagarajan Vaidehi and Mailman, {Richard B.}",
year = "2012",
month = "6",
day = "1",
doi = "10.1124/mol.111.075457",
language = "English (US)",
volume = "81",
pages = "820--831",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

Receptor conformations involved in dopamine D 2L receptor functional selectivity induced by selected transmembrane-5 serine mutations. / Fowler, J. Corey; Bhattacharya, Supriyo; Urban, Jonathan D.; Vaidehi, Nagarajan; Mailman, Richard B.

In: Molecular pharmacology, Vol. 81, No. 6, 01.06.2012, p. 820-831.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Receptor conformations involved in dopamine D 2L receptor functional selectivity induced by selected transmembrane-5 serine mutations

AU - Fowler, J. Corey

AU - Bhattacharya, Supriyo

AU - Urban, Jonathan D.

AU - Vaidehi, Nagarajan

AU - Mailman, Richard B.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Although functional selectivity is now widely accepted, the molecular basis is poorly understood. We have studied how aspects of transmembrane region 5 (TM5) of the dopamine D 2Lreceptor interacts with three rationally selected rigid ligands (dihydrexidine, dinapsoline, and dinoxyline) and the reference compounds dopamine and quinpirole. As was expected from homology modeling, mutation of three TM5 serine residues to alanine (S5.42A, S5.43A, S5.46A) had little effect on antagonist affinity. All three mutations decreased the affinity of the agonist ligands to different degrees, S5.46A being somewhat less affected. Four functions [adenylate cyclase (AC), extracellular signal-regulated kinase 1/2 phosphorylation (MAPK), arachidonic acid release (AA), and guanosine 5′-O-(3-thio)triphosphate binding (GTPγS)] were assessed. The intrinsic activity (IA) of quinpirole was unaffected by any of the mutations, whereas S5.42A and S5.46A mutations abolished the activity of dopamine and the three rigid ligands, although dihydrexidine retained IA at MAPK function only with S5.42A. Remarkably, S5.43A did not markedly affect IA for AC and MAPK for any of the ligands and eliminated AA activity for dinapsoline and dihydrexidine but not dinoxyline. These data suggest that this mutation did not disrupt the overall conformation or signaling ability of the mutant receptors but differentially affected ligand activation. Computational studies indicate that these D 2 agonists stabilize multiple receptor conformations. This has led to models showing the stabilized conformations and interhelical and receptor-ligand contacts corresponding to the different activation pathways stabilized by various agonists. These data provide a basis for understanding D 2L functional selectivity and rationally discovering functionally selective D 2 drugs.

AB - Although functional selectivity is now widely accepted, the molecular basis is poorly understood. We have studied how aspects of transmembrane region 5 (TM5) of the dopamine D 2Lreceptor interacts with three rationally selected rigid ligands (dihydrexidine, dinapsoline, and dinoxyline) and the reference compounds dopamine and quinpirole. As was expected from homology modeling, mutation of three TM5 serine residues to alanine (S5.42A, S5.43A, S5.46A) had little effect on antagonist affinity. All three mutations decreased the affinity of the agonist ligands to different degrees, S5.46A being somewhat less affected. Four functions [adenylate cyclase (AC), extracellular signal-regulated kinase 1/2 phosphorylation (MAPK), arachidonic acid release (AA), and guanosine 5′-O-(3-thio)triphosphate binding (GTPγS)] were assessed. The intrinsic activity (IA) of quinpirole was unaffected by any of the mutations, whereas S5.42A and S5.46A mutations abolished the activity of dopamine and the three rigid ligands, although dihydrexidine retained IA at MAPK function only with S5.42A. Remarkably, S5.43A did not markedly affect IA for AC and MAPK for any of the ligands and eliminated AA activity for dinapsoline and dihydrexidine but not dinoxyline. These data suggest that this mutation did not disrupt the overall conformation or signaling ability of the mutant receptors but differentially affected ligand activation. Computational studies indicate that these D 2 agonists stabilize multiple receptor conformations. This has led to models showing the stabilized conformations and interhelical and receptor-ligand contacts corresponding to the different activation pathways stabilized by various agonists. These data provide a basis for understanding D 2L functional selectivity and rationally discovering functionally selective D 2 drugs.

UR - http://www.scopus.com/inward/record.url?scp=84861419372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861419372&partnerID=8YFLogxK

U2 - 10.1124/mol.111.075457

DO - 10.1124/mol.111.075457

M3 - Article

C2 - 22416052

AN - SCOPUS:84861419372

VL - 81

SP - 820

EP - 831

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -